Insulin-Based Versus Triple Oral Therapy for Newly Diagnosed Type 2 Diabetes
- Ildiko Lingvay, MD, MPH, MSCS1,
- Jaime L. Legendre, BS1,
- Polina F. Kaloyanova, MD1,
- Song Zhang, PHD2,
- Beverley Adams-Huet, MS1,2 and
- Philip Raskin, MD1
- 1Department of Internal Medicine, Division of Endocrinology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas;
- 2Department of Clinical Sciences, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas.
- Corresponding author: Ildiko Lingvay, .